HERE IS A SUMMARY OF THE SECOND QUARTER FINANCIAL PERFORMANCE of the largest IVD manufacturers serving clinical laboratories. Lab managers and pathologists can use this information to track the market successes or setbacks by the different IVD vendors. These insights can be particularly helpful when considering different companies when it is time to replace or […]
Global IVD Companies Issue Third Quarter 2024 Earnings
Nearly all in vitro diagnostics firms report modest growth, discuss plans for 2025
- By Robert Michel
- > From the Volume XXXI, No. 16 - November 25, 2024 Issue
- Tags: Abbott Laboratories, Aptima BV CV/TV, BD, BD COR, BD MAX IVD, Beckman Coulter Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, BioFire, bioMerieux, Biopharma, Biotheranostics Inc., Brian Blaser, Cepheid, clinical assay, clinical chemistry, COVID-19, Danaher, ddPCR, digital pcr, DNA, droplet digital PCR assay, Flu A, Flu B, Hologic, immunoassay, immunodiagnostics, in vitro diagnostics, integrated diagnostics, IVD, ivd/lab informatics, leica biosystems, life sciences, LumiraDx, Marc Casper, microbiology, molecular biology, molecular diagnostics, multi-modal technology, Norman Schwartz, QIAcuityDx, Qiagen, QuidelOrtho, respiratory assay, Respiratory syncytial virus, RNA, Robert Ford, Roche Group, RSV, Savanna, Siemens Healthineers, Stephen McMillan, sysmex, Thermo Fisher Scientific
